Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
about
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaeditDihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaArtemisinin-based combination therapies: a vital tool in efforts to eliminate malariaThe effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient dataArtemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trialA randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in PeruAn open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in AsiaRandomized controlled trials of malaria intervention trials in Africa, 1948 to 2007: a descriptive analysisPopulation Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.Longitudinal survey of Plasmodium falciparum infection in Vietnam: characteristics of antimalarial resistance and their associated factorsEffects of a high-fat meal on the relative oral bioavailability of piperaquineProtective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved ToolEfficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in IndonesiaThe story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study.A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central VietnamContrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugsEfficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites.Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed?In vitro cardiovascular effects of dihydroartemisin-piperaquine combination compared with other antimalarialsThe efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.Antimalarial drugs: current status and new developments.In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model.Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.Efficacy and safety of dihydroartemisinin-piperaquine.Prospects for the treatment of drug-resistant malaria parasites.MMV in partnership: the Eurartesim® experience.
P2860
Q21032449-D601FA8B-3394-479D-99B0-42C4C86CA4CDQ24201077-ED558851-048B-4AF3-A351-68DA56F74747Q24614989-C1DDF480-C083-4FF6-8BD9-5A01C80C5AD7Q26822489-23BFECCA-EC87-496D-9063-3692875588FAQ28469217-E34C4388-45DD-4AAF-A94F-4B1D36C58859Q28469333-AB6D6D8F-2F87-4187-BBD6-750210945740Q28474978-13DF616A-77B3-4CFD-9C94-81088F82C942Q30499150-F68D52EF-4E36-4D40-9280-B6B87C49395CQ31153944-2D128A64-AB5C-4A9B-927E-EC42F2523BF3Q33276757-6EBA4E37-7F5F-46D4-8C26-3105574E65E1Q33279066-E75E1B1A-AA8C-4778-8802-A3BD9578D14BQ33298467-CFCC77E8-657C-44FD-ACA7-0B54B9992CADQ33342827-5C054925-0DFE-4D39-9263-018B5DB88142Q33489551-AD012876-8EE8-4846-9EA0-AD19DE61AA92Q33614155-370B3271-41D7-40D8-B816-AF1069001B6EQ33836733-3C09D300-4AAB-4BC8-848B-EC5E15F8EF4DQ33875677-46EBF8EB-0B92-4FD1-A611-92888824BCA1Q34254961-D46C9A78-C933-4406-AD5A-3331CE2DCBE6Q34329292-537D479B-271C-4FDF-9ABD-E8F81EEE4B60Q34341784-5DD72C52-0077-40AB-B4D4-80CC6C95BF36Q34597617-3B1970D1-7B05-417F-A920-6FE440889DF9Q34677891-AE0622CD-B3A1-4061-B601-0EF5B3441F55Q34973806-DD34F55A-2343-426D-BCAE-698E51F04F6DQ35086214-F2EF33AE-E3A7-43B0-8910-450F6638D39BQ35139505-EB96A644-E10F-48DB-AB83-F81121E473C1Q35189138-43A1E285-3390-4F32-B35A-67556F0DB387Q35598379-FECDBC8C-45BB-4BD0-99C8-F9669F06F83AQ35652102-AFCD020E-BFE1-4551-B95F-17F530ECB3B0Q36018689-A4E8E2C1-FF84-4E87-85FF-6E49E4F3CE26Q36138872-257776DC-132F-42E0-B0AC-313FDBAFD9A5Q36179156-44208DC5-2CB1-4CE0-985D-CCA161CCD5B9Q36196479-1F7D1CE0-1942-4C9F-83AE-183E8AFDBBEEQ36418265-FD13BC92-FEE3-46C0-B9D4-FE0E8DFA98C3Q36422652-792F4FFC-A4C3-49CA-BA2E-F6824E025227Q36422706-F93798DF-C04A-48F1-8488-A35525DB4507Q36482878-FC0AD4E4-79A5-4EBF-AB84-DC409AAED465Q36552289-285DAE7B-BF92-40BC-B5B7-A7E5768B8341Q36894516-725A4FAD-AA74-4013-9E79-ED39F34AB3FFQ36895758-08AB77BE-C7E0-41FA-9AEA-769C87D78BDAQ36952896-AE4DCDEC-4637-4535-A6F8-B6EFFFF42B4A
P2860
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Dihydroartemisinin-piperaquine ...... am: randomised clinical trial.
@en
Dihydroartemisinin-piperaquine ...... am: randomised clinical trial.
@nl
type
label
Dihydroartemisinin-piperaquine ...... am: randomised clinical trial.
@en
Dihydroartemisinin-piperaquine ...... am: randomised clinical trial.
@nl
prefLabel
Dihydroartemisinin-piperaquine ...... am: randomised clinical trial.
@en
Dihydroartemisinin-piperaquine ...... am: randomised clinical trial.
@nl
P2093
P50
P921
P1433
P1476
Dihydroartemisinin-piperaquine ...... am: randomised clinical trial.
@en
P2093
Hong Thai Le
Phuong Mai Pham
Tan Thanh Tran
Thanh Truong Nguyen
Thi Dung Nguyen
Thi Hoai An Dong
Tinh Hien Tran
P356
10.1016/S0140-6736(03)15163-X
P407
P577
2004-01-01T00:00:00Z